Filtros de búsqueda

Lista de obras de Inge Marie Svane

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A Promiscuous Survivin-Derived T-Cell Epitope Restricted to the HLA-A3 Super-Type Alleles

artículo científico publicado en 2012

A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

artículo científico publicado en 2021

A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysis

artículo científico publicado en 2008

ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors

artículo científico publicado en 2021

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity

artículo científico publicado en 2015

Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?

artículo científico publicado en 2014

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.

artículo científico publicado en 2017

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

artículo científico publicado en 2002

Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function.

artículo científico publicado en 2009

Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

artículo científico publicado en 2020

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

artículo científico publicado en 2012

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

artículo científico publicado en 2018

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types

artículo científico publicado en 2021

Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma

artículo científico publicado en 2019

Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2.

artículo científico publicado en 2008

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

artículo científico publicado en 2012

Analysis of survivin-specific T cells in breast cancer patients using human DCs engineered with survivin mRNA.

artículo científico

Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs

artículo científico publicado en 2014

Antigen-specific T-cell immunity in multiple myeloma patients is restored following high-dose therapy: implications for timing of vaccination

artículo científico publicado en 2007

Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

artículo científico publicado en 2019

Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

artículo científico publicado en 2020

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

artículo científico publicado en 2020

Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma

scientific article published on 01 April 2020

Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.

artículo científico publicado en 2016

B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment

scientific article published on 18 August 2019

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

artículo científico publicado en 2012

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

artículo científico publicado en 2011

Broadening the repertoire of melanoma-associated T-cell epitopes.

artículo científico publicado en 2015

CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment.

artículo científico publicado en 2016

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

artículo científico publicado en 2009

CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene

scientific article published on 01 August 2000

CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer

artículo científico publicado en 2020

Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer

artículo científico publicado en 2016

Cancer immunotherapy in patients with brain metastases.

artículo científico publicado en 2018

Cancer immunotherapy in patients with preexisting autoimmune disorders

artículo científico publicado en 2016

Cancer treatment: the combination of vaccination with other therapies

artículo científico publicado en 2008

Cell culture plastics with immobilized interleukin-4 for monocyte differentiation

article

Cellular based cancer vaccines: type 1 polarization of dendritic cells.

artículo científico

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2

artículo científico publicado en 2011

Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

artículo científico publicado en 2020

Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.

artículo científico publicado en 2012

Characterization of Monocyte-Derived Dendritic Cells Maturated With IFN-alpha

artículo científico publicado en 2006

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

artículo científico publicado en 2012

Characterization of T-cell responses against IκBα in cancer patients

artículo científico publicado en 2012

Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patients

article

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

artículo científico publicado en 2011

Characterization of risk factors and efficacy of medical management of immune-related hepatotoxicity in real-world patients with metastatic melanoma treated with immune checkpoint inhibitors

scientific article published on 28 March 2020

Checkpoint inhibitors in breast cancer - Current status

artículo científico publicado en 2017

Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice

artículo científico publicado en 1996

Clinical Impact of the Number of Treatment Cycles in First-Line Docetaxel for Patients With Metastatic Castration-Resistant Prostate Cancer

artículo científico publicado en 2016

Clinical application of dendritic cells in cancer vaccination therapy

artículo científico publicado en 2003

Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model

artículo científico publicado en 2017

Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy

artículo científico publicado en 2022

Collagen density regulates the activity of tumor-infiltrating T cells

artículo científico publicado en 2019

Comment on “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy” by Gustav J. Ullenhag et al ⬇️

artículo científico publicado el 20 de marzo de 2012

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

artículo científico publicado en 2020

Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy

artículo científico publicado en 2012

Comparison of α-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients

artículo científico publicado en 2008

Confinement dependent chemotaxis in two-photon polymerized linear migration constructs with highly definable concentration gradients

artículo científico publicado en 2015

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

artículo científico publicado en 2019

Cutaneous adverse reactions to anti-PD-1 treatment - a systematic review

scientific article published on 19 April 2020

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

artículo científico publicado en 2019

Dendrite cell-based cancer vaccines--clinical application

artículo científico publicado en 2006

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

artículo científico publicado en 2017

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients

artículo científico publicado en 2013

Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05

artículo científico publicado en 2015

Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab.

artículo científico publicado en 2018

Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses - implications for the management of irAEs

artículo científico publicado en 2018

Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs

scientific article published on 07 January 2019

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

artículo científico publicado en 2019

Dissection of T-cell Antigen Specificity in Human Melanoma

artículo científico publicado en 2012

Durable Clinical Responses and Long-Term Follow-Up of Stage III-IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study-A Brief Research Report

article

Effector and regulatory T cells in patients with acute optic neuritis

artículo científico publicado en 2012

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma

artículo científico publicado en 2013

Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis

artículo científico publicado en 2019

Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip

artículo científico publicado en 2011

Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient

artículo científico publicado en 2006

Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells

scientific article published on 01 July 2019

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

artículo científico publicado en 2019

Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.

artículo científico publicado en 2014

Expression of beta 2-microglobulin by premalignant epithelium

artículo científico publicado en 1993

FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma

artículo científico publicado en 2012

Frequent adaptive immune responses against arginase-1.

artículo científico publicado en 2017

Functional characterization of Foxp3-specific spontaneous immune responses.

artículo científico publicado en 2013

Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion

artículo científico publicado en 2012

Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

scientific article published on 20 January 2020

HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice

scientific article published on 08 January 2019

HLA-B35-restricted immune responses against survivin in cancer patients

article

HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

scientific article published on 17 January 2013

Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway

artículo científico publicado en 2013

High MHC class I expression correlates with slow growth in UV-induced skin carcinomas in hairless mice

scientific article published on 01 November 1998

High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review

artículo científico publicado en 2004

High dose chemotherapy versus conventional chemotherapy in metastasing breast cancer. An analysis of a systematic Cochrane review

artículo científico publicado en 2004

High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals.

artículo científico publicado en 2019

High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer

artículo científico publicado en 2010

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

artículo científico publicado en 2019

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy

artículo científico publicado en 2022

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

artículo científico publicado en 2010

Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

artículo científico publicado en 2009

Identification of novel survivin-derived CTL epitopes

artículo científico publicado en 2004

Immune Monitoring Using mRNA-Transfected Dendritic Cells.

artículo científico publicado en 2016

Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate

artículo científico publicado en 2009

Immune selection in murine tumors. A study of MCA induced sarcomas in normal and immunodeficient mice

scientific article published on 01 January 1998

Immune selection in murine tumors. Ph.d thesis.

artículo científico publicado en 2003

Immunogenicity of Bcl-2 in patients with cancer

artículo científico publicado en 2004

Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab

artículo científico publicado en 2015

Immunoprofiles of colorectal cancer from Lynch syndrome

artículo científico publicado en 2018

Immunotherapy for metastatic colorectal cancer: present status and new options

artículo científico publicado en 2012

Immunotherapy is cancer treatment with a novel side-effect profile ⬇️

artículo científico publicado en 2017

Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method

artículo científico publicado en 2002

Impaired circulating myeloid DCs from myeloma patients

artículo científico publicado en 2004

Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma

artículo científico publicado en 2006

In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes

artículo científico publicado en 2020

In-chip fabrication of free-form 3D constructs for directed cell migration analysis.

artículo científico publicado en 2013

Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-

artículo científico publicado en 2011

Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.

artículo científico publicado en 2010

Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma

artículo científico publicado en 2010

Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin

artículo científico publicado en 2009

Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

artículo científico publicado en 2017

Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

artículo científico publicado en 2010

Indoleamine 2,3-dioxygenase vaccination

artículo científico publicado en 2015

Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes

article

Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.

artículo científico publicado en 2017

Interferon-gamma-Induced MHC Class I Expression and Defects in Jak/Stat Signalling in Methylcholanthrene-Induced Sarcomas

artículo científico publicado en 1997

Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera

artículo científico publicado en 2015

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

artículo científico publicado en 2017

Isolated asymptomatic masseter muscle metastasis as first sign of metastatic disease in a patient with known melanoma

Large-Scale mRNA Transfection of Dendritic Cells by Electroporation in Continuous Flow Systems.

artículo científico publicado en 2016

Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.

artículo científico publicado en 2016

Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab.

artículo científico publicado en 2014

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

artículo científico

Long-Term Exposure to Inflammation Induces Differential Cytokine Patterns and Apoptosis in Dendritic Cells

scientific article published on 21 November 2019

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase

artículo científico publicado en 2013

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase

artículo científico publicado en 2013

Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?

artículo científico publicado en 2015

MCA Sarcomas Induced in scid Mice are More Immunogenic than MCA Sarcomas Induced in Congenic, Immunocompetent Mice

scientific article published on 01 May 1997

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells

scientific article published on 02 July 2019

MHC class II-bound self-peptides can be effectively separated by isoelectric focusing and bind optimally to their MHC class II restriction elements around pH 5.0

artículo científico publicado en 1994

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

artículo científico publicado en 2012

Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion

artículo científico publicado en 2012

Molecular aberrations in the MHC class I-restricted pathway for antigen presentation in methylcholanthrene sarcomas from nude mice: discrepancies between MHC mRNA and surface protein

scientific article published on 01 August 1997

More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers

artículo científico publicado en 2015

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

artículo científico publicado en 2017

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

artículo científico

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase

artículo científico publicado en 2012

Neuroprotective and anti-inflammatory mechanisms are activated early in optic neuritis

artículo científico publicado en 2015

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

artículo científico publicado en 2015

Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients

scholarly article by Christina Jensen et al published 19 December 2018 in Journal for Immunotherapy of Cancer

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies

artículo científico publicado en 2018

Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

scientific article published on 01 June 2020

P18-02. Peptide pulsed dendritic cells allows for induction of polyfunctional CD4+ T cell responses and help CD8+ T cell targeting subdominant CTL epitopes

article

PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer

artículo científico publicado en 2017

PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy

scientific article published on 31 January 2017

PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine.

artículo científico publicado en 2016

Peptide Super-Agonist Enhances T-Cell Responses to Melanoma

article

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

artículo científico publicado en 2022

Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

artículo científico publicado en 2016

Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.

artículo científico publicado en 2018

Peripheral memory T cells specific for Arginase-1

scientific article published on 10 May 2019

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma

artículo científico publicado en 2022

Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)

artículo científico publicado en 2023

Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination

artículo científico publicado en 2005

Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with metastatic melanoma.

artículo científico publicado en 2015

Predictors of Chemotherapy-Induced Toxicity and Treatment Outcomes in Elderly Versus Younger Patients With Metastatic Castration-Resistant Prostate Cancer

artículo científico publicado en 2016

Principles of adoptive T cell therapy in cancer

scientific article published on 05 September 2018

Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma

artículo científico publicado en 2020

Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)

artículo científico publicado en 2022

Rapid Identification of the Tumor-Specific Reactive TIL Repertoire Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens

artículo científico publicado en 2021

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

artículo científico publicado en 2019

Real-world evidence to guide healthcare policies in oncology

artículo científico publicado en 2019

Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies.

artículo científico

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

artículo científico publicado en 2008

RhoC a new target for therapeutic vaccination against metastatic cancer

artículo científico publicado en 2008

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial

scientific article published on 19 October 2010

Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab

artículo científico publicado en 2016

Selective costimulation by IL-15R/IL-15, but not IL-2R/IL-2, allows the induction of high numbers of tumor-specific CD8+ T cells by human dendritic cells matured in conditions of acute inflammation.

artículo científico publicado en 2015

Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells ⬇️

artículo científico publicado el 1 de junio de 2013

Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor

artículo científico publicado en 2014

Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes

artículo científico publicado en 2017

Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.

artículo científico publicado en 2004

Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response

article

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

artículo científico publicado en 2011

Spontaneous presence of FOXO3-specific T cells in cancer patients.

artículo científico publicado en 2014

Studies on mRNA Electroporation of Immature and Mature Dendritic Cells: Effects on their Immunogenic Potential

artículo científico publicado en 2008

Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease

artículo científico publicado en 2014

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

scientific article published on 01 February 2019

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

artículo científico publicado en 2017

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients

artículo científico publicado en 2019

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients

artículo científico publicado en 2014

T cells isolated from patients with checkpoint inhibitor resistant-melanoma are functional and can mediate tumor regression.

artículo científico publicado en 2018

T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road

artículo científico publicado en 2020

T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy.

artículo científico publicado en 2018

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

artículo científico publicado en 2020

The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag).

artículo científico publicado en 2009

The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

artículo científico publicado en 2016

The Danish Melanoma Database

artículo científico publicado en 2016

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.

artículo científico publicado en 2016

The Susceptibility to Cytotoxic T Lymphocyte Mediated Lysis of Chemically Induced Sarcomas from Immunodeficient and Normal Mice

scientific article published on 01 January 1997

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy.

artículo científico publicado en 2017

The controversial role of TNF in melanoma

artículo científico publicado en 2015

The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro

artículo científico publicado en 2020

The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells

artículo científico publicado en 2013

The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

artículo científico publicado en 2009

The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

artículo científico publicado en 2008

The immunogenicity of the hTERT540-548 peptide in cancer

artículo científico publicado en 2008

The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.

artículo científico publicado en 2017

The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials.

artículo científico publicado en 2017

The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

scientific article published on 01 June 2020

The real-world impact of modern treatments on the survival of patients with metastatic melanoma

scientific article published on 31 December 2018

The real-world outcome of metastatic melanoma: Unknown primary vs. known cutaneous

scientific article published on 03 September 2019

The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunity

artículo científico publicado en 2014

The targeting of indoleamine 2,3 dioxygenase -mediated immune escape in cancer

artículo científico

The universal character of the tumor-associated antigen survivin

artículo científico publicado en 2007

Therapeutic Vaccination against A Modified Minimal Survivin Epitope Induces Functional CD4 T Cells That Recognize Survivin-Expressing Cells

artículo científico publicado en 2016

Therapeutic cancer vaccines in combination with conventional therapy

artículo científico publicado en 2010

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

artículo científico publicado en 2008

Therapeutic dendritic cell vaccination of patients with renal cell carcinoma

artículo científico publicado en 2006

Transcriptomic signatures of tumors undergoing T cell attack

artículo científico publicado en 2021

Transfection of Tumor-Infiltrating T Cells with mRNA Encoding CXCR2

artículo científico publicado en 2016

Treatment of BRAF-mutated metastatic melanoma ⬇️

artículo científico publicado en 2016

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

artículo científico publicado en 2015

Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures

artículo científico publicado en 2011

Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma.

artículo científico publicado en 2015

Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations

scientific article published on 12 March 2020

Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions

artículo científico publicado en 2022

Tumor-infiltrating lymphocytes for the treatment of metastatic cancer.

artículo científico

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

scientific article published on 05 February 2019

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

artículo científico publicado en 2023

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

artículo científico publicado en 2010

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

artículo científico publicado en 2007

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

artículo científico publicado en 2004

Wildtype p53-specific antibody and T-cell responses in cancer patients

artículo científico publicado en 2011

[Cancer immune therapy for the treatment of haematological malignancies] ⬇️

artículo científico publicado en 2019

[Chimeric antigen receptor T-cell therapy] ⬇️

artículo científico publicado en 2019

[Immunotherapy for patients with malignant melanoma and brain metastases] ⬇️

scientific article published on 01 June 2019

mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda